TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23168396

Group type: EXPERIMENTAL
Intervention: X-STOP interspinous spacer
Number of subjects: 55
Study: 24707475

Group type: EXPERIMENTAL
Intervention: Specific strength training (SST, n = 18)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: General fitness training (GFT, n = 16)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Reference group without physical training (REF, n = 8)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Healthy controls (CON, n = 20)
Number of subjects: 42
Study: 22144539

Group type: EXPERIMENTAL
Intervention: Zidovudine plus enteric-coated didanosine plus lopinavir and ritonavir for 7 days
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Zidovudine plus enteric-coated didanosine for 30 days
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Regimen 1 for 30 days
Number of subjects: 169

Group type: COMPARATOR
Intervention: Historical comparison group (received prenatal zidovudine and SD-NVP)
Number of subjects: 169
Study: 20453481

Group type: EXPERIMENTAL
Intervention: Washing the biopsy needle with povidone-iodine (Group 1, n = 84)
Number of subjects: 180

Group type: COMPARATOR
Intervention: No washing of the biopsy needle (Group 2, n = 96)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 180
Study: 17666602

Group type: EXPERIMENTAL
Intervention: Endocervical curettage (ECC)
Number of subjects: 1119

Group type: COMPARATOR
Intervention: Colposcopically directed biopsy
Number of subjects: 1119

Group type: EXPERIMENTAL
Intervention: Combined sensitivity of ECC and biopsy
Number of subjects: 1119
Study: 15599137

Group type: EXPERIMENTAL
Intervention: Bupivacaine (0.5%)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Bupivacaine (0.5%) + S(+) ketamine (75 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Bupivacaine (0.5%) + Ketorolac (60 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (Bupivacaine only)
Number of subjects: 36
Study: 12102303

Group type: EXPERIMENTAL
Intervention: Rifampicin and ethambutol
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Rifampicin, ethambutol and isoniazid
Number of subjects: 75
Study: 9523804

Group type: EXPERIMENTAL
Intervention: Hyperbaric 5% lidocaine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Hyperbaric 5% prilocaine
Number of subjects: 200
Study: 8130055

Group type: EXPERIMENTAL
Intervention: Alfentanil 1 mg as a bolus i.v. injection 15 s before propofol
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 22
Study: 2632532

Group type: EXPERIMENTAL
Intervention: metronidazole 400mg tid
Number of subjects: 137
Study: 1091161

Group type: EXPERIMENTAL
Intervention: Doxepin
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 35
Study: 31941466

Group type: EXPERIMENTAL
Intervention: Simulated patients' feedback during Objective Structured Clinical Exam (OSCE) on communication skills
Number of subjects: 80

Group type: COMPARATOR
Intervention: Pre-test scores on Liverpool Communication Skills Assessment Scale (LCSAS)
Number of subjects: 80
Study: 31299077

Group type: EXPERIMENTAL
Intervention: Plaque Reduction Neutralization Test (PRNT)
Number of subjects: 3990

Group type: EXPERIMENTAL
Intervention: Enzyme-Linked Immunosorbent Assay (ELISA)
Number of subjects: 3990

Group type: COMPARATOR
Intervention: ELISA threshold of 51.7 ELISA units/mL
Number of subjects: 3990

Group type: COMPARATOR
Intervention: Correlation between PRNT and ELISA
Number of subjects: 3990
Study: 28701597

Group type: EXPERIMENTAL
Intervention: Milrinone low-dose infusion at 0.375 μg/kg/min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Milrinone medium-dose infusion at 0.5 μg/kg/min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Milrinone high-dose infusion at 0.75 μg/kg/min
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 25307771

Group type: EXPERIMENTAL
Intervention: Carnoy's solution (CS)
Number of subjects: 110

Group type: COMPARATOR
Intervention: 10% neutral buffered formalin solution (NBF)
Number of subjects: 110
Study: 24046430

Group type: EXPERIMENTAL
Intervention: Cassava (CASS)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Broken rice (BROK)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Corn (CRN)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Nonmolted control (CONT)
Number of subjects: 240
Study: 21929764

Group type: EXPERIMENTAL
Intervention: Terlipressin (TP) 1 μg/kg/hour
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Arginine vasopressin (AVP) 0.04 U/minute
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (isotonic saline)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Terlipressin (TP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Arginine vasopressin (AVP)
Number of subjects: 60
Study: 19219665

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 17068314

Group type: COMPARATOR
Intervention: Sertraline (selective serotonin reuptake inhibitor); specific dosage and duration not mentioned.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo; specific dosage and duration not mentioned.
Number of subjects: 0
Study: 12640354

Group type: EXPERIMENTAL
Intervention: Cefaclor (CEF) 20 mg/kg/d for 10 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate (AMC) 25 mg/kg/d for 10 days
Number of subjects: 100
Study: 11242548

Group type: EXPERIMENTAL
Intervention: Telephonic case management using an interactive voice response system (IVR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: General project (control group)
Number of subjects: 0
Study: 9344167

Group type: EXPERIMENTAL
Intervention: Oral controlled-release (CR)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Transdermal (TDD)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral transmucosal (TMD)
Number of subjects: 12
Study: 8199078

Group type: EXPERIMENTAL
Intervention: Continuous oestrogen/progestin treatment
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Cyclic sequential oestrogen/progestin treatment
Number of subjects: 68

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Five years treatment with oestradiol/norethisterone
Number of subjects: 68
Study: 2889258

Group type: EXPERIMENTAL
Intervention: Famotidine 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Famotidine 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Famotidine 20 mg
Number of subjects: 0
Study: 30526528

Group type: EXPERIMENTAL
Intervention: 50 mg hydrochlorothiazide
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: 25 mg hydrochlorothiazide
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: 12.5 mg hydrochlorothiazide
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study: 28813255

Group type: EXPERIMENTAL
Intervention: Incredible Years parenting intervention
Number of subjects: 387
Study: 26198582

Group type: EXPERIMENTAL
Intervention: Greater number of vegetables tried at age 14 months
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Greater number of fruits and noncore foods tried at age 14 months
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Exposure to a variety of fruits and vegetables
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Limited noncore food exposure from an early age
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Fussiness at age 14 months
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Child body mass index z score
Number of subjects: 340
Study: 23506581

Group type: EXPERIMENTAL
Intervention: Renal nerve blockade
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 18
Study: 21885675

Group type: EXPERIMENTAL
Intervention: Baseline levels of lipocalin 2
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Total and free leptin levels
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Lipocalin 2 levels
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: HOMA-IR
Number of subjects: 272
Study: 19467049

Group type: EXPERIMENTAL
Intervention: Heat treatment at 440 degrees C for 30 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heat treatment at 440 degrees C for 10 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heat treatment at 500 degrees C for 30 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heat treatment at 500 degrees C for 10 min
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonheat-treated specimens
Number of subjects: 0
Study: 16461145

Group type: EXPERIMENTAL
Intervention: Wheat (25 g)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Cooked wheat challenge
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Provocation dose
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Specific IgE
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Skin test with commercial wheat extract
Number of subjects: 27
Study: 15560810

Group type: EXPERIMENTAL
Intervention: Experimental test whitening toothpaste
Number of subjects: 23

Group type: COMPARATOR
Intervention: Water control
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Commercial whitening toothpaste
Number of subjects: 23
Study: 11771000

Group type: EXPERIMENTAL
Intervention: Histamine phosphate at a concentration of 4 mg/mL
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline phosphate provocation
Number of subjects: 20
Study: 9032515

Group type: EXPERIMENTAL
Intervention: Entonox (50% nitrous oxide and 50% oxygen)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Gas chromatography method for TL,CO determination
Number of subjects: 5
Study: 7684512

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.5 to 1.0 microgram per day orally) plus salmon calcitonin (400 IU per day intranasally)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.5 to 1.0 microgram per day orally) plus placebo nasal spray
Number of subjects: 103

Group type: COMPARATOR
Intervention: Calcium (1000 mg per day orally)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Calcitonin plus calcitriol
Number of subjects: 103

Group type: COMPARATOR
Intervention: Calcium alone
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Calcitriol
Number of subjects: 103
Study: 2963380

Group type: EXPERIMENTAL
Intervention: Intravenous administration of carbazochrome sodium sulfonate (AC-17)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 30511966

Group type: EXPERIMENTAL
Intervention: Active low-level laser therapy (Riancorp LTU-904)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Inactive low-level laser therapy (placebo)
Number of subjects: 42
Study: 25878160

Group type: EXPERIMENTAL
Intervention: Marsh pharmacokinetic model
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: PGIMER pharmacokinetic model
Number of subjects: 23
Study: 24959347

Group type: EXPERIMENTAL
Intervention: Steroid-free immunosuppressive protocol based on low-dose tacrolimus and mycophenolate mofetil (MMF) with antithymocyte globulin (ATG) induction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional immunosuppressive protocol based on low-dose tacrolimus, MMF, and steroids with interleukin-2 receptor (IL2-R) induction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both study arms
Number of subjects: 0
Study: 22430565

Group type: EXPERIMENTAL
Intervention: MRI after surgical debridement and initiation of antibiotic therapy
Number of subjects: 12
Study: 20593535

Group type: EXPERIMENTAL
Intervention: gemcitabine 1000 mg/m2 on days 1 and 8 plus carboplatin area under the curve 5.5 on day 1 (n = 47)
Number of subjects: 1135

Group type: EXPERIMENTAL
Intervention: gemcitabine 1000 mg/m2 on days 1 and 8 plus paclitaxel 200 mg/m2 on day 1 (n = 42)
Number of subjects: 1135

Group type: EXPERIMENTAL
Intervention: paclitaxel 225 mg/m2 on day 1 plus carboplatin area under the curve 6.0 on day 1 (n = 49)
Number of subjects: 1135

Group type: EXPERIMENTAL
Intervention: Standard chemotherapy doublet regimens (overall for white and African American patients)
Number of subjects: 1135
Study: 18713910

Group type: EXPERIMENTAL
Intervention: Closed suctioning during pressure‐controlled ventilation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Closed suctioning during volume‐controlled ventilation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Open suctioning
Number of subjects: 20
Study: 15652392

Group type: EXPERIMENTAL
Intervention: Clonidine (0.1 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham smoking
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cigarette smoking
Number of subjects: 12
Study: 12972792

Group type: EXPERIMENTAL
Intervention: Papanicolaou test
Number of subjects: 1008

Group type: COMPARATOR
Intervention: Polymerase chain reaction (PCR)
Number of subjects: 1008
Study: 12862135

Group type: EXPERIMENTAL
Intervention: ALM+BCG
Number of subjects: 80

Group type: COMPARATOR
Intervention: BCG
Number of subjects: 80
Study: 8831305

Group type: EXPERIMENTAL
Intervention: Aprotinin treatment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no aprotinin)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: TNF stimulated A549 cell culture supernatant
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Aprotinin and TLCK
Number of subjects: 16
Study: 8398225

Group type: EXPERIMENTAL
Intervention: Worksite mammography program (print media, on-site workshops, and incentive drawings)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control site (comparison site)
Number of subjects: 0
Study: 3100312

Group type: EXPERIMENTAL
Intervention: Etidronate 7.5 mg kg‐1 body weight
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29596311

Group type: EXPERIMENTAL
Intervention: exercise + isoflavone supplementation (ISO)
Number of subjects: 32

Group type: COMPARATOR
Intervention: exercise + placebo (PLA)
Number of subjects: 32
Study: 28077538

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 44

Group type: COMPARATOR
Intervention: Isotonic saline (Control)
Number of subjects: 44
Study: 24958603

Group type: EXPERIMENTAL
Intervention: enalapril + candesartan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: enalapril + hydrochlorothiazide (HCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 0
Study: 22499373

Group type: EXPERIMENTAL
Intervention: Alendronate sodium (B)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Sodium fluoride (C)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (A)
Number of subjects: 26
Study: 21160258

Group type: EXPERIMENTAL
Intervention: Chemotherapy for older women with high-risk breast cancer features
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery, endocrine therapy, and radiotherapy
Number of subjects: 0
Study: 18549460

Group type: EXPERIMENTAL
Intervention: Tacrolimus therapy
Number of subjects: 27
Study: 15988077

Group type: EXPERIMENTAL
Intervention: Mildronate
Number of subjects: 110

Group type: COMPARATOR
Intervention: Conventional treatment (diuretics, ACE inhibitors, beta-blockers, digoxin)
Number of subjects: 110
Study: 12717125

Group type: EXPERIMENTAL
Intervention: Pancuronium 15 microg/kg followed by mivacurium 0.1 mg/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline followed by mivacurium 0.13 mg/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pancuronium-mivacurium group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Mivacurium group
Number of subjects: 20
Study: 10547085

Group type: EXPERIMENTAL
Intervention: Vitamin C (2 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8669518

Group type: EXPERIMENTAL
Intervention: Simple advice
Number of subjects: 1559

Group type: EXPERIMENTAL
Intervention: Brief counseling
Number of subjects: 1559

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1559
Study: 2058827

Group type: EXPERIMENTAL
Intervention: Fentanyl group (n = 10): bolus injections of about 0.2 mg/h fentanyl and 2.5 mg/h midazolam
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ketamine group (n = 10): infusion of about 50 mg/h ketamine and 2.5 mg/h midazolam
Number of subjects: 20
Study: 6327346

Group type: EXPERIMENTAL
Intervention: 5 mg terbutaline sulphate orally
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.5 mg terbutaline sulphate subcutaneously
Number of subjects: 8

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 8
Study: 31334793

Group type: EXPERIMENTAL
Intervention: Filgotinib 200 mg
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Filgotinib 100 mg
Number of subjects: 448

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 448
Study: 29584549

Group type: EXPERIMENTAL
Intervention: Carboplatin-Paclitaxel-Trastuzumab (experimental arm)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Carboplatin-Paclitaxel (control arm)
Number of subjects: 61
Study: 27230022

Group type: EXPERIMENTAL
Intervention: Mitii (multi-modal web-based rehabilitation) for 20 weeks, 30 minutes per day, 6 days per week
Number of subjects: 58

Group type: COMPARATOR
Intervention: Usual care (wait list control)
Number of subjects: 58
Study: 24606670

Group type: EXPERIMENTAL
Intervention: CERAMENT™ BONE VOID FILLER (CBVF)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Autologous iliac crest bone graft
Number of subjects: 136
Study: 22577718

Group type: EXPERIMENTAL
Intervention: Antithyroid drug and Caltrate D (600 mg/day)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Antithyroid drug, Caltrate D (600 mg/day), and Alendronate (70 mg weekly)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (21 healthy voluntary adults)
Number of subjects: 27
Study: 20008417

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Dexamethasone and Glycerol
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: Glycerol
Number of subjects: 383

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 383
Study: 17272253

Group type: EXPERIMENTAL
Intervention: Active warming and humidification of inspired gases (Group HUM)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ventilation without airway warming and exogenous humidification (Group C-control)
Number of subjects: 200
Study: 16274306

Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (propylene glycol alginate [PGA])
Number of subjects: 30
Study: 12145006

Group type: EXPERIMENTAL
Intervention: Oat cereal
Number of subjects: 36

Group type: COMPARATOR
Intervention: Wheat cereal
Number of subjects: 36
Study: 10442322

Group type: EXPERIMENTAL
Intervention: Ossein-hydroxyapatite compound (OHC) 3.32 g/d
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Calcium carbonate 2.5 g/d
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment-free control group
Number of subjects: 60
Study: 7842191

Group type: EXPERIMENTAL
Intervention: Home monitoring of peak expiratory flow rate (PEFR) with educational intervention
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group using symptoms and spirometric data
Number of subjects: 70
Study: 2359576

Group type: EXPERIMENTAL
Intervention: Daily home uterine activity monitoring and perinatal nursing support
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 67
Study: 364637

Group type: EXPERIMENTAL
Intervention: Ibuprofen 1200 mg daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Indomethacin 75 mg daily
Number of subjects: 60
Study: 31358624

Group type: EXPERIMENTAL
Intervention: Reappraising academic and social adversity intervention
Number of subjects: 1304

Group type: COMPARATOR
Intervention: Control condition activities
Number of subjects: 1304
Study: 30053074

Group type: EXPERIMENTAL
Intervention: Exercise intervention (brisk walking), adherence 166.0±66.1 minutes/week
Number of subjects: 144

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Exercise intervention (brisk walking)
Number of subjects: 144
Study: 26346408

Group type: EXPERIMENTAL
Intervention: TDM (therapeutic drug monitoring)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Standard dosing (clinician-driven)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study: 22974254

Group type: EXPERIMENTAL
Intervention: Beraprost sodium (BPS) 40 µg, tid for 8 weeks
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Beraprost sodium (BPS)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 21901911

Group type: EXPERIMENTAL
Intervention: New health benefit plan changes for obese employees
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: New health benefit plan changes focused on obesity
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: New health benefit plan changes focused on tobacco use
Number of subjects: 658
Study: 18567066

Group type: EXPERIMENTAL
Intervention: Consider‐An‐Alternative debiasing procedure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 17896582

Group type: EXPERIMENTAL
Intervention: Alpha-ketoglutaric acid calcium salt (6 g AKG and 1.68 Ca/day)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Calcium alone (1.68 Ca/day)
Number of subjects: 76
Study: 14719145

Group type: EXPERIMENTAL
Intervention: Laxative group (lactulose)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Constipated group (codeine phosphate)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 105
Study: 12439361

Group type: EXPERIMENTAL
Intervention: Fenoldopam; specific agonism of dopamine‐1 receptors; details on dosage and duration not available
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo; control group in randomized trial
Number of subjects: 0
Study: 9625684

Group type: EXPERIMENTAL
Intervention: Enalapril, 10 mg/d
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 7948230

Group type: EXPERIMENTAL
Intervention: Trial solution (1.36% glucose and 1% peptides, 381 mOsm/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control solution (2.27% glucose, 404 mOsm/kg)
Number of subjects: 20
Study: 3345279

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with adrenaline 1 in 200,000
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.5% bupivacaine plain
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.5% bupivacaine
Number of subjects: 80
Study: 29169605

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 2199

Group type: COMPARATOR
Intervention: Enoxaparin-warfarin
Number of subjects: 2199